This report contains market size and forecasts of In Vitro Toxicity in Global, including the following market information:
Global In Vitro Toxicity Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global In Vitro Toxicity market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the In Vitro Toxicity companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Vitro Toxicity Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global In Vitro Toxicity Market Segment Percentages, By Type, 2020 (%)
Dose Response
Threshold Response
China In Vitro Toxicity Market, By Application, 2016-2021, 2022-2027 ($ millions)
China In Vitro Toxicity Market Segment Percentages, By Application, 2020 (%)
Distribution
Excretion
Metabolism
Global In Vitro Toxicity Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global In Vitro Toxicity Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total In Vitro Toxicity Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total In Vitro Toxicity Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Agilent Technologies
Covance
Bio-Rad Laboratories
General Electric
Eurofins Scientific
BioReliance
Charles River Laboratories International
Thermo Fisher Scientific
Catalent
Cyprotex
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 In Vitro Toxicity Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In Vitro Toxicity Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In Vitro Toxicity Overall Market Size
2.1 Global In Vitro Toxicity Market Size: 2021 VS 2027
2.2 Global In Vitro Toxicity Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In Vitro Toxicity Players in Global Market
3.2 Top Global In Vitro Toxicity Companies Ranked by Revenue
3.3 Global In Vitro Toxicity Revenue by Companies
3.4 Top 3 and Top 5 In Vitro Toxicity Companies in Global Market, by Revenue in 2020
3.5 Global Companies In Vitro Toxicity Product Type
3.6 Tier 1, Tier 2 and Tier 3 In Vitro Toxicity Players in Global Market
3.6.1 List of Global Tier 1 In Vitro Toxicity Companies
3.6.2 List of Global Tier 2 and Tier 3 In Vitro Toxicity Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global In Vitro Toxicity Market Size Markets, 2021 & 2027
4.1.2 Dose Response
4.1.3 Threshold Response
4.2 By Type - Global In Vitro Toxicity Revenue & Forecasts
4.2.1 By Type - Global In Vitro Toxicity Revenue, 2016-2021
4.2.2 By Type - Global In Vitro Toxicity Revenue, 2022-2027
4.2.3 By Type - Global In Vitro Toxicity Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global In Vitro Toxicity Market Size, 2021 & 2027
5.1.2 Distribution
5.1.3 Excretion
5.1.4 Metabolism
5.2 By Application - Global In Vitro Toxicity Revenue & Forecasts
5.2.1 By Application - Global In Vitro Toxicity Revenue, 2016-2021
5.2.2 By Application - Global In Vitro Toxicity Revenue, 2022-2027
5.2.3 By Application - Global In Vitro Toxicity Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global In Vitro Toxicity Market Size, 2021 & 2027
6.2 By Region - Global In Vitro Toxicity Revenue & Forecasts
6.2.1 By Region - Global In Vitro Toxicity Revenue, 2016-2021
6.2.2 By Region - Global In Vitro Toxicity Revenue, 2022-2027
6.2.3 By Region - Global In Vitro Toxicity Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America In Vitro Toxicity Revenue, 2016-2027
6.3.2 US In Vitro Toxicity Market Size, 2016-2027
6.3.3 Canada In Vitro Toxicity Market Size, 2016-2027
6.3.4 Mexico In Vitro Toxicity Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe In Vitro Toxicity Revenue, 2016-2027
6.4.2 Germany In Vitro Toxicity Market Size, 2016-2027
6.4.3 France In Vitro Toxicity Market Size, 2016-2027
6.4.4 U.K. In Vitro Toxicity Market Size, 2016-2027
6.4.5 Italy In Vitro Toxicity Market Size, 2016-2027
6.4.6 Russia In Vitro Toxicity Market Size, 2016-2027
6.4.7 Nordic Countries In Vitro Toxicity Market Size, 2016-2027
6.4.8 Benelux In Vitro Toxicity Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia In Vitro Toxicity Revenue, 2016-2027
6.5.2 China In Vitro Toxicity Market Size, 2016-2027
6.5.3 Japan In Vitro Toxicity Market Size, 2016-2027
6.5.4 South Korea In Vitro Toxicity Market Size, 2016-2027
6.5.5 Southeast Asia In Vitro Toxicity Market Size, 2016-2027
6.5.6 India In Vitro Toxicity Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America In Vitro Toxicity Revenue, 2016-2027
6.6.2 Brazil In Vitro Toxicity Market Size, 2016-2027
6.6.3 Argentina In Vitro Toxicity Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa In Vitro Toxicity Revenue, 2016-2027
6.7.2 Turkey In Vitro Toxicity Market Size, 2016-2027
6.7.3 Israel In Vitro Toxicity Market Size, 2016-2027
6.7.4 Saudi Arabia In Vitro Toxicity Market Size, 2016-2027
6.7.5 UAE In Vitro Toxicity Market Size, 2016-2027
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies In Vitro Toxicity Major Product Offerings
7.1.4 Agilent Technologies In Vitro Toxicity Revenue in Global (2016-2021)
7.1.5 Agilent Technologies Key News
7.2 Covance
7.2.1 Covance Corporate Summary
7.2.2 Covance Business Overview
7.2.3 Covance In Vitro Toxicity Major Product Offerings
7.2.4 Covance In Vitro Toxicity Revenue in Global (2016-2021)
7.2.5 Covance Key News
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Corporate Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories In Vitro Toxicity Major Product Offerings
7.3.4 Bio-Rad Laboratories In Vitro Toxicity Revenue in Global (2016-2021)
7.3.5 Bio-Rad Laboratories Key News
7.4 General Electric
7.4.1 General Electric Corporate Summary
7.4.2 General Electric Business Overview
7.4.3 General Electric In Vitro Toxicity Major Product Offerings
7.4.4 General Electric In Vitro Toxicity Revenue in Global (2016-2021)
7.4.5 General Electric Key News
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Corporate Summary
7.5.2 Eurofins Scientific Business Overview
7.5.3 Eurofins Scientific In Vitro Toxicity Major Product Offerings
7.5.4 Eurofins Scientific In Vitro Toxicity Revenue in Global (2016-2021)
7.5.5 Eurofins Scientific Key News
7.6 BioReliance
7.6.1 BioReliance Corporate Summary
7.6.2 BioReliance Business Overview
7.6.3 BioReliance In Vitro Toxicity Major Product Offerings
7.6.4 BioReliance In Vitro Toxicity Revenue in Global (2016-2021)
7.6.5 BioReliance Key News
7.7 Charles River Laboratories International
7.7.1 Charles River Laboratories International Corporate Summary
7.7.2 Charles River Laboratories International Business Overview
7.7.3 Charles River Laboratories International In Vitro Toxicity Major Product Offerings
7.4.4 Charles River Laboratories International In Vitro Toxicity Revenue in Global (2016-2021)
7.7.5 Charles River Laboratories International Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific In Vitro Toxicity Major Product Offerings
7.8.4 Thermo Fisher Scientific In Vitro Toxicity Revenue in Global (2016-2021)
7.8.5 Thermo Fisher Scientific Key News
7.9 Catalent
7.9.1 Catalent Corporate Summary
7.9.2 Catalent Business Overview
7.9.3 Catalent In Vitro Toxicity Major Product Offerings
7.9.4 Catalent In Vitro Toxicity Revenue in Global (2016-2021)
7.9.5 Catalent Key News
7.10 Cyprotex
7.10.1 Cyprotex Corporate Summary
7.10.2 Cyprotex Business Overview
7.10.3 Cyprotex In Vitro Toxicity Major Product Offerings
7.10.4 Cyprotex In Vitro Toxicity Revenue in Global (2016-2021)
7.10.5 Cyprotex Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. In Vitro Toxicity Market Opportunities & Trends in Global Market
Table 2. In Vitro Toxicity Market Drivers in Global Market
Table 3. In Vitro Toxicity Market Restraints in Global Market
Table 4. Key Players of In Vitro Toxicity in Global Market
Table 5. Top In Vitro Toxicity Players in Global Market, Ranking by Revenue (2019)
Table 6. Global In Vitro Toxicity Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global In Vitro Toxicity Revenue Share by Companies, 2016-2021
Table 8. Global Companies In Vitro Toxicity Product Type
Table 9. List of Global Tier 1 In Vitro Toxicity Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In Vitro Toxicity Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global In Vitro Toxicity Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - In Vitro Toxicity Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - In Vitro Toxicity Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global In Vitro Toxicity Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - In Vitro Toxicity Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - In Vitro Toxicity Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global In Vitro Toxicity Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global In Vitro Toxicity Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global In Vitro Toxicity Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America In Vitro Toxicity Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America In Vitro Toxicity Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe In Vitro Toxicity Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe In Vitro Toxicity Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia In Vitro Toxicity Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia In Vitro Toxicity Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America In Vitro Toxicity Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America In Vitro Toxicity Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa In Vitro Toxicity Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa In Vitro Toxicity Revenue, (US$, Mn), 2022-2027
Table 30. Agilent Technologies Corporate Summary
Table 31. Agilent Technologies In Vitro Toxicity Product Offerings
Table 32. Agilent Technologies In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 33. Covance Corporate Summary
Table 34. Covance In Vitro Toxicity Product Offerings
Table 35. Covance In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories In Vitro Toxicity Product Offerings
Table 38. Bio-Rad Laboratories In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 39. General Electric Corporate Summary
Table 40. General Electric In Vitro Toxicity Product Offerings
Table 41. General Electric In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 42. Eurofins Scientific Corporate Summary
Table 43. Eurofins Scientific In Vitro Toxicity Product Offerings
Table 44. Eurofins Scientific In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 45. BioReliance Corporate Summary
Table 46. BioReliance In Vitro Toxicity Product Offerings
Table 47. BioReliance In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 48. Charles River Laboratories International Corporate Summary
Table 49. Charles River Laboratories International In Vitro Toxicity Product Offerings
Table 50. Charles River Laboratories International In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific In Vitro Toxicity Product Offerings
Table 53. Thermo Fisher Scientific In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 54. Catalent Corporate Summary
Table 55. Catalent In Vitro Toxicity Product Offerings
Table 56. Catalent In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
Table 57. Cyprotex Corporate Summary
Table 58. Cyprotex In Vitro Toxicity Product Offerings
Table 59. Cyprotex In Vitro Toxicity Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. In Vitro Toxicity Segment by Type
Figure 2. In Vitro Toxicity Segment by Application
Figure 3. Global In Vitro Toxicity Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global In Vitro Toxicity Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global In Vitro Toxicity Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In Vitro Toxicity Revenue in 2020
Figure 8. By Type - Global In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 9. By Application - Global In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 10. By Region - Global In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 11. By Country - North America In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 12. US In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 13. Canada In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 16. Germany In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 17. France In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 19. Italy In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 20. Russia In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 24. China In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 25. Japan In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 28. India In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 30. Brazil In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa In Vitro Toxicity Revenue Market Share, 2016-2027
Figure 33. Turkey In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 34. Israel In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 36. UAE In Vitro Toxicity Revenue, (US$, Mn), 2016-2027
Figure 37. Agilent Technologies In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Covance In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bio-Rad Laboratories In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. General Electric In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eurofins Scientific In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. BioReliance In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Charles River Laboratories International In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher Scientific In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Catalent In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Cyprotex In Vitro Toxicity Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Agilent Technologies
Covance
Bio-Rad Laboratories
General Electric
Eurofins Scientific
BioReliance
Charles River Laboratories International
Thermo Fisher Scientific
Catalent
Cyprotex